MedMira's HIV test gets approval in China

By Elaine Rigoli

Tampa, Fla., May 17 - MedMira, Inc. received approval from the State Food and Drug Administration of the People's Republic of China for its MiraWell Rapid HIV Test for use with whole blood specimens.

MedMira said its test is the only whole-blood rapid HIV test to fulfill the rigorous clinical requirements of the Chinese regulatory body.

The MiraWell HIV test offers users instant results and has a shelf life of two years at room temperature storage, the company said in a news release.

With whole blood approval now in place, MedMira said it will develop market opportunities in the over-the-counter sector for further penetration into China.

Located in Halifax, Nova Scotia, MedMira manufactures in-vitro flow-through rapid diagnostic tests.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.